Signal Transduction in Anaplastic Large Cell Lymphoma Cells (ALCL) Mediated by the Tumor Necrosis Factor Receptor CD30

References

• Stein, H., Foss, H.D., Darkop, H., Marafioti, T., Delsol, G., Pulford, K., et al. (2000) "CD30( +) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features", Blood, 96, 3681— 3695.
   Google Scholar
• Morris, SM., Xue, L., Ma, Z. and Kinney, M.C. (2001) "ALK CD30 ± lymphomas: A distinct molecular genetic subtype of Non-Hodgkin's Lymphoma", British Journal of Haematology, 113, 275–295.
   Google Scholar
• Chiarle, R., Podda, A., Prolla, G., Gong, J., Thorbecke, G.J. and Inghirami, G. (1999) "CD30 in normal and neoplastic cells", Clinical Immunology, 90, 157 — 164. Review.
   Google Scholar
• Dffikop, H., Latza, U., Hummel, M., Eitelbach, F., Seed, B. and Stein, H. (1992) "Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease", Cell, 68, 421–427.
   Google Scholar
• Drexler, HG., Gignac, SM., von Wasielewski, R., Werner, M. and Dirks, WG. (2000) "Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas", Leukemia, 14(9), 1533–1559.
   PubMed Web of Science ®Google Scholar
• McDonald, P.P., Cassatella, MA., Bald, A., Maggi, E., Romagna-iii, S., Gruss, R.I., et al. (1995) "CD30 ligation induces nuclear factor-kappa B activation in human T cell lines", European Journal of Immunology, 25, 2870–2876.
   PubMed Web of Science ®Google Scholar
• Smith, CA., Gruss, R.I., Davis, T., Anderson, D., Farrah, T., Baker, E., et al. (1993) "CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF", Cell, 73, 1349–1360.
   Google Scholar
• Tian, Z.G., Longo, DL., Funakoshi, S., Asai, O., Ferris, D.K., Widmer, M.,et al. (1995) "In vivo antitumor effects ofunconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenografts", Cancer Research, 55, 5335–5341.
   PubMed Web of Science ®Google Scholar
• Grell, M., Zimmermann, G., Gottfried, E., Chen, CM., Grunwald, U., Huang, D.C., et al. (1999) "Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF", EMBO Journal, 18, 3034–3043.
   Google Scholar
• Mir, S.S., Richter, B.W. and Duckett, C.S. (2000) "Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells", Blood, 96, 4307–4312.
   PubMed Web of Science ®Google Scholar
• Hsu, P.L. and Hsus, S.M. (2000) "Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma", Laboratory Investigation, 80, 1111–1119.
   Google Scholar
• Htibinger, G., Scheffrahn, I., Miller, E., Bai, R., Duyster, J., Morris, SM., et al. (1999) "The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracel-lular domain of the surface receptor CD30 but is not activated by CD30 stimulation", Experimental Hematology, 27, 1796— 1805.
   Web of Science ®Google Scholar
• Htibinger, G., Willer, E., Scheffrahn, I., Schneider, C., Hildt, C., Singer, B.B., et al. (2001) "CD30-mediated cell cycle arrest associated with induced expression of p21 CIP1/WAF1 in the anaplastic large cell lymphoma cell line Karpas 299", Oncogene, 20, 590–598.
   PubMed Web of Science ®Google Scholar
• Muta, H., Boise, L.H., Fang, L. and Podack, E.R. (2000) "CD30 signals integrate expression of cytotoxic effector molecules, lym-phocyte trafficking signals, and signals for proliferation and apoptosis", Journal of Immunology, 165, 5105–5111.
   PubMed Web of Science ®Google Scholar
• Levi, E., Wang, Z., Petrogiannis-Haliotis, T., Pfeifer, W.M., Kempf, W., Drews, R., et al. (2000) "Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression", Journal of Investigative Dermatology, 115, 1034 —1040.
   Google Scholar
• Merz, H., Lange, K., Gaiser, T., Willer, A., Kapp, U., Bittner, C., et al. (2002) "Characterization of a Novel Human Anaplastic Large Cell Lymphoma Cell Line Tumorigenic in SCID Mice",Leukemia & Lymphoma, 43, 165–172.
   Google Scholar
• Friesen, C., Herr, I., Krammer, P.H. and Debatin, K.M. (1996) "Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells", Nature Medicine, 2, 574— 577.
   Google Scholar
• Stansfeld, AG., Diebold, J., Kapanci, G., Lennert, K., Miodus-zewska, O., Noel, R., et al. (1988) "Updated Kiel classification for lymphomas", Lancet, 1, 292–603.
   PubMed Web of Science ®Google Scholar
• Harris, N.L., Jaffe, ES., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, ML., et al. (1994) "A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group", Blood, 84, 1361–1392.
   Google Scholar
• Koon, H.B. and Junghans, R.P. (2000) "Anti-CD30 antibody-based therapy", Current Opinion in Oncology, 12, 588 — 593.
   Google Scholar
• Pfeifer, W., Levi, E., Petrogiannis-Haliotis, T., Lehmann, L., Wang, Z. and Kadin, M.E. (1999) "A murine xenograft model for human CD30 + anaplastic large cell lymphoma. Successful growth inhibi-tion with an anti-CD30 antibody (HeFi-1)", American Journal of Pathology, 155, 1353–1359.
   PubMed Web of Science ®Google Scholar
• Schneider, C. and Habinger, G. (2002) "Pleiotropic signal transduction mediated by human CD30, a member of the tumor necrosis factor receptor (TNFR) family", Leukemia & Lymphoma, 43, 1355 — 1366.
   Google Scholar
• Nakano, H., Shindo, M., Sakon, S., Nishinaka, S., Mihara, M., Yagita, H., et al. (1998) "Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1", Proceedings of the National Academy of Sciences of the United States of America, 95, 3537–3542.
   PubMed Web of Science ®Google Scholar
• Dadgostar, H. and Cheng, G. (2000) "Membrane localization of TRAF 3 enables JNK activation", Journal of Biological Chemistry, 275, 2539 — 2544.
   Google Scholar
• Kashiwada, M., Shirakata, Y., Inoue, J.I., Nakano, H., Okazaki, K., Okumura, K., et al. (1998) "Tumor necrosis factor receptor-associated kinase (ERK) activity in CD40 signaling along a ras-independent pathway", Journal of Experimenal Medicine, 87, 237 — 244.
   Google Scholar
• Hatzoglou, A., Roussel, J., Bourgeade, M.F., Rogier, E., Madry, C., Inoue, J., et al. (2000) "TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase". Journal of Immunology, 165, 1322 — 1330.
   PubMed Web of Science ®Google Scholar